期刊文献+

核型异常急性非淋巴细胞白血病111例临床分析 被引量:1

Clinical analysis of 111 cases of acute non-lymphocytic leukemia with pathological karyotypes
原文传递
导出
摘要 目的探讨异常核型的急性非淋巴细胞白血病(ANLL)患者近期疗效。方法R显带法进行核型分析。观察组和对照组分别含111例核型异常和69例核型正常ANLL患者。结果异常核型组完全缓解(CR)率明显低于正常核型组(44.14%对65.22%;P<0.01)。非t(8;21)核型异常组的ANLL患者CR率明显低于正常核型组(28.57%对65.22%;P<0.005)。结论伴复杂核型异常的ANLL疗效较差。 ObjectiveTo explore the therapeutic effect of acute non-lymphocytic leukemia(ANLL) with pathological karyotypes.MethodsAnalyze karyotype with the R-banding technique.The experimental group contained 111 ANLL patients with pathological karyotypes and the control group contained 69 ANLL patients with normal karyotypes.ResultsThe complete remission (CR) rate was apparently lower in the group of pathological karyotypes than that in the group of normal karyotypes (44.14% vs 65.22%;P<0.01).CR rate was apparently lower in the group of non-t (8;21) pathological karyotypes than that in the group of normal karyotypes(28.57% vs 65.22%;P<0.005).ConclusionANLL with complex pathological karyotypes is associated with poor prognosis.
作者 孟小莉
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2005年第5期417-418,共2页 Chinese Journal of Practical Internal Medicine
关键词 核型 白血病 非淋巴细胞 临床分析 治疗 诊断 Karyotype Leukemia Non-lymphocytic
  • 相关文献

参考文献4

  • 1Nguyen S,Leblanc T,Fenaux P,et al.A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML):a survey of 161 cases from the French AML Intergroup.Blood,2002,99(10):3517-3523.
  • 2Byrd JC,Mrozek K,Dodge RK,et al.Pretreatment cytogenetic abnormalities are predictive of induction success,cumulative incidence of relapse,and overall survival in adult patients with de novo acute myeloid leukemia:results from Cancer and Leukemia Group B (CALGB 8461).Blood,2002,100(13):4325-4336.
  • 3Sun T,Wu E.Acute monoblastic leukemia with t(8;16):a distinct clinico-pathologic entity-report of a case and review of the literature.Am J Hematol,2001,66(3):207-212.
  • 4Baldus C,Fietz T,Rieder H,et al.MDR-1 expression and deletions of chromosomes 7 and 5(Q) separately indicate adverse prognosis in AML.Leuk Lymphoma,2001,40(5-6):613-623.

同被引文献12

  • 1Harbott J, Mancini M, Verellen-Dumoulin C, et al. Hematological malignancies with a deletion of 11 q23 :cytogenetic and clinical aspects. European 11 q23 Workshop participants [ J ]. Leukemia,1998,12 (5) :823 - 827.
  • 2Johansson B, Moorman AV, Haas OA, et al. Hematologic malignancies with t (4 ; 11 ) ( q21 ; q23 ) - a cytogenetic, morphologic, immunophenotypic and clinical study of 183 cases. European 11q23 Workshop participants [ J ]. Leukemia, 1998,12 ( 5 ) :779 - 787.
  • 3The Groupe Francais de Cytogenetique Hematologique. Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings and outcome. A collaborative study of the Groupe Francais de Cytogenetique Hematologique [J]. Blood, 1996,87(8) :3135 -3142.
  • 4Cimino G, Elia L, Mancini M, et al. Clinico-biologic features and treatment outcome of adult pro-B-ALL patients enrolled in the GIMEMA 0496 study:absence of the ALL1/AF4 and of the BCR/ ABL fusion genes correlates with a significantly better clinical outcome [ J ]. Blood ,2003,102 (6) :2014 - 2020.
  • 5Swansbury G J, Slater R, Bain B J, et al. Hematological malignancies with t (9 ; 11 ) ( p21 - 22 ; q23 ) - a laboratory and clinical study of 125 cases. European 11 q23 Workshop participants [ J ]. Leukemia, 1998,12 ( 5 ) :792 - 800.
  • 6Chillon CM ,Garcia-Sanz R, Balanzategui A, et al. Molecular characterization of acute myeloblastic leukemia according to the new WHO classification:a different distribution in Central-West Spain [J]. Haematologica,2001,86(2 ) : 162 - 166.
  • 7Grimwade D,Walker H, Oliver F, et al. The importance of diagnostic cytogenetics on outcome in AML:analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties [ J ]. Blood, 1998,92(7 ) :2322 - 2333.
  • 8Slovak ML,Kopecky K J, Cassileth PA, et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia:a Southwest Oncology Group/Eastem Cooperative Oncology Group Study [ J ]. Blood, 2000, 96 ( 13 ) :4075 - 4083.
  • 9Byrd JC, Mrozek K, Dodge RK, et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse,and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B( CALGB 8461 ) [ J ] , Blood, 2002, 100 ( 13 ) : 4325 - 4336.
  • 10过宇,薛永权,谢新,吴德沛,李建勇,陆定伟,蒋复高,耿美菊.11q23异常恶性血液病的临床和细胞遗传学研究[J].中华医学遗传学杂志,2000,17(2):72-75. 被引量:10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部